Novel mechanism of drug resistance in kala azar field isolates

Journal of Infectious Diseases

Volumn 188, Issue 4, 2003, Pages 600-607

  Singh, Neeloo ^a   Singh, Ramsing Th ^a   Sundar, Shyam ^b  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

^b BANARAS HINDU UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIMONY GLUCONATE; PROTOZOAL DNA;

ARTICLE; CHROMOSOME 9; CONTROLLED STUDY; DNA SEQUENCE; FEVER; GENE IDENTIFICATION; GENE LOCUS; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; INDIA; LEISHMANIA; LEISHMANIA DONOVANI; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMASTIGOTE; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SPLEEN SIZE; VISCERAL LEISHMANIASIS;

ADULT; ANIMALS; ANTIPROTOZOAL AGENTS; BASE SEQUENCE; DRUG RESISTANCE; FEMALE; GENES, PROTOZOAN; HUMANS; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; MALE; MOLECULAR SEQUENCE DATA; OPEN READING FRAMES; PHENOTYPE;

EID: 0041941359     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/377133     Document Type: Article

References (30)

1. Ganguly NK. Oral miltefosine may revolutionize treatment of visceral leishmaniasis. Special Program for Research and Training in Tropical Diseases News. Report no. 68. Geneva: United Nations Development Programme/World Bank/World Health Organization, 2002.
2. Sundar S, More DK, Singh MK. Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic. Clin Infect Dis 2000; 31:1104-7.
3. Borst P, Ouellette M. New mechanisms of drug resistance in parasitic protozoa. Annu Rev Microbiol 1995; 49:427-60.
4. Higgins CF. ABC Transporters. From microorganisms to man. Annu Rev Cell Biol 1992; 8:67-113.
5. Ouellette M, Fase-Fowler F, Borst P. The amplified H circle of methotrexate-resistant Leishmania tarentolae contains a novel P-glycoprotein gene. EMBO J 1990; 9:1027-1033.
6. Legare D, Papadopoulou B, Roy G, et al. Efflux systems and increased trypanothione levels in arsenite resistant Leishmania species. Exp Parasitol 1997; 87:275-82.
7. Roberts WL, Berman JD, Rainey PM. In vitro antileishmanial properties of tri- and pentavalent antimonial preparations. Antimicrob Agents Chemother 1995; 39:1234-9.
8. Sereno D, Cavaleyra M, Zemzoumi K, Maquaire S, Ouaissi A, Lemesre JL. Axenically grown amastigotes of Leishmania infantum used as an in vitro model to investigate the pentavalent antimony mode of action. Antimicrob Agents Chemother 1998; 42:3097-102.
9. Shaked-Mishan P, Ulrich N, Ephros M, Zilberstein D. Novel intracellular SbV reducing activity correlates with antimony susceptibility in Leishmania donovani. J Biol Chem 2001; 276:3971-6.
10. Dey S, Papadopoulou B, Haimeur A, et al. High level of arsenite resistance in Leishmania tarentolae is mediated by an active extrusion system. Mol Biochem Parasitol 1994; 67:49-57.
11. Dey S, Ouellette M, Lightbody J, Papdopoulou B, Rosen BP. An ATP-dependent As(III)-glutathione transport system in membrane vesicles of Leishmania tarentolae. Proc Natl Acad Sci 1996; 93:2192-7.
12. Singh N. Is there true Sb(V) resistance in Indian kala azar field isolates? Curr Science 2000; 83:101-2.
13. Chulay JD, Bryceson ADM. Quantitation of amastigotes of Leishmania donovani in smears of splenic aspirates from patients with visceral leishmaniasis. Am J Trop Med Hyg 1983; 32:475-9.
14. Maniatis T, Fritsch EF, Sambrook J. Molecular cloning: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Press, 1982.
15. Liu X, Chang K.-P. The 63-kb circular amplicon of tunicamycin resistant Leishmania amazonensis contains a functional N-acetylglucosamine-1-phosphate transferase gene that can be used as a dominant selectable marker in transfection. Mol Cell Biol 1992; 12:4112-22.
16. Haimeur A, Ouellette M. Gene amplification in Leishmania tarentolae selected for resistance to sodium stibogluconate. Antimicrob Agents Chemother 1998; 42:1689-94.
17. Kaur J, Dey CS. Putative P-glycoprotein expression in arsenite-resistant Leishmania donovani down-regulated by verapamil. Biochem Biophys Res Commun 2000; 271:615-9.
18. Arana FE, Perez-Victoria J M, Repetto Y, Morello A, Cast S, Gamarro F. Involvement of thiol metabolism in resistance to glucantime in Leishmania tropica. Biochem Pharmacol 1998; 56:1201-8.
19. Morwira ES, Anacleto C, Petrillo-Peixoto ML. Effect of glucantime on field and patient isolates of New World Leishmania: use of growth parameters of promastigotes to assess antimony susceptibility. Parasitol Res 1998; 84:720-61.
20. Murta SMF, Santos WG, Anacleto C, Nirde P, Moreira ESA, Romanha AJ. Drug resistance in Trypanosoma cruzi is not associated with amplification or overexpression of P-glycoprotein (PGP) genes. Mol Biochem Parasitol 2001; 117:223-8.
21. Mukhopadhyay R, Dey S, Xu N, et al. Trypanothione overproduction and resistance to antimonials and arsenicals in Leishmania tarentolae. Proc Natl Acad Sci USA 1996; 93:10383-7.
22. Ouellette M, Danielle L, Haimeur A, Grondin K, Roy G, Brochu C, Papadopoulou B. ABC transporters in Leishmania and their role in drug resistance. Drug Res Updates 1998; 1:43-8.
23. Haimeur A, Brochu C, Genest PA, Papadopoulou B, Ouellette M. Amplification of the ABC transporter gene PGPA and increased trypanothione levels in potassium antimonyl tartrate (SbIII) resistant Leishmania tarentolae. Mol Biochem Parasitol 2000; 108:131-5.
24. Matthews KR, Tschudi C, Ullu E. A common pyrimidine-rich motif governs trans-splicing and polyadenylation of tubulin polycistronic pre-mRNA in trypanosomes. Genes Dev 1994; 8:491-501.
25. Button LL, McMaster WR. Molecular cloning of the major surface antigen of Leishmania. J Exp Med 1998; 167:724-9.
26. Langford CK, Ullman B, Landfear SM. Leishmania: codon utilization of nuclear genes. Exp Parasitol 1992; 74:360-1.
27. Conseil G, Perez-Victoria JM, Jault JM, et al. Protein kinase C effectors bind to multidrug ABC transporters and inhibit their activity. Biochemistry 2001; 40:2564-71.
28. Prasad V, Dey CS. Tubulin is hyperphosphorylated on serine and tyrosine residues in arsenite-resistant L donovani promastigotes. Parasitol Res 2000; 86:876-80.
29. Salotra P, Ralhan R, Sreenivas G. Heat stress-induced modulation of protein phosphorylation in virulent promastigotes of L. donovani. Int J Biochem Cell Biol 2000; 32:309-16.
30. Ephros M, Bitnun A, Shaked P, Waldman E, Zilberstein D. Stage-specific activity of pentavalent antimony against Leishmania donovani axenic amastigotes. Antimicrob Agents Chemother 1999; 43:278-82.